Slc6a6−/− KIT+ AML LSCs from established disease formed 2.9-fold fewer colonies compared with the controls (Fig. 3l), indicating that TAUT loss depleted functional LSCs. This evidence concerns the gene SLC6A6 and acute myeloid leukemia.